Skip to content

Casting the first stone: the US Christian right’s war on the Global Fund

PEPFAR and Global Fund both highly effective, but is the funding sustainable?

Is PEPFAR competing or cooperating in treatment scale-up?

Cigarette smoking may undermine benefits of potent antiretroviral therapy

Should anal Pap smears be introduced for people with HIV?

Diagnosis with pulmonary KS still `ominous` even in era of potent HIV therapy

Darunavir (TMC114) approved for use in treatment-experienced patients in US

Grey nails help predict need to start anti-HIV therapy in Malawians

PEPFAR project reports reduction in the number of partners among Zambian truck drivers

PEPFAR: HIV prevention for injection drug users in Africa a growing issue

Rapid tests boost HIV diagnosis rate in US

Mortality and causes of death amongst people taking HIV treatment in Senegal examined

Untested HIV-positive individuals account for up to 70% of sexually transmitted HIV infections in US, estimates CDC

AZT/3TC/tenofovir regimen effective first-line therapy in resource-limited settings

US activists 'applaud' darunavir (Prezista, TMC114) pricing

Two generic HIV drugs approved for children by FDA

Malnourishment at time HIV treatment is started equals much poorer survival

Fatty liver prevalence high with HIV/HCV coinfection: 'use ddI or d4T cautiously'